bf/NASDAQ:CNTA_icon.jpeg

NASDAQ:CNTA

Centessa Pharmaceuticals plc

  • Stock

USD

Last Close

22.84

06/11 21:01

Market Cap

3.92B

Beta: -

Volume Today

595.10K

Avg: 172.13K

PE Ratio

−5.00

PFCF: −4.38

OverviewFinancialsAPI

    Description

    Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2.5-2-1.5-1-0.52020-03-312021-06-012022-03-302022-12-312024-05-102025-03-27

    Revenue (Estimate*)

    1M2M3M4M5M6M7M2020-03-312021-06-012022-03-302022-12-312024-05-102025-03-27

    *Estimate based on analyst consensus